Your browser doesn't support javascript.
loading
Cost-effectiveness model for a hypothetical monotherapy vs standard of care in adult patients with treatment-resistant depression.
Wang, Si-Tien; Anderson, Ian M; Mitchell, Dominic; Johnson, Scott J; Shiozawa, Aki.
Affiliation
  • Wang ST; Medicus Economics, LLC, Boston, MA, USA.
  • Anderson IM; Neuroscience and Psychiatry Unit, University of Manchester and Manchester Academic Health Science Centre, Manchester, UK.
  • Mitchell D; Medicus Economics, LLC, Repentigny, QC, Canada.
  • Johnson SJ; Medicus Economics, LLC, Boston, MA, USA.
  • Shiozawa A; Department of Health Policy and Management, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA, ashioza3@jhu.edu.
Clinicoecon Outcomes Res ; 11: 257-270, 2019.
Article in En | MEDLINE | ID: mdl-30936731
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Health_economic_evaluation / Prognostic_studies Aspects: Patient_preference Language: En Journal: Clinicoecon Outcomes Res Year: 2019 Document type: Article Affiliation country: Country of publication:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Health_economic_evaluation / Prognostic_studies Aspects: Patient_preference Language: En Journal: Clinicoecon Outcomes Res Year: 2019 Document type: Article Affiliation country: Country of publication: